ANIP vs VMC · rev $614.4M vs P/E 35, rev $7.42B
ANI Pharmaceuticals Inc (ANIP) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported ANIP revenue for 2024-12-31 was $614.4M. Net income was -$18.5M. Revenue was up 26.2% from 2023-12-31 to 2024-12-31. ANIP currently screens at market cap $1.41B.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
ANIP currently screens at market cap $1.41B. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the ANIP and VMC stock pages for the full models.
Not investment advice.